Rxivist logo

Rxivist combines preprints from bioRxiv with data from Twitter to help you find the papers being discussed in your field. Currently indexing 65,085 bioRxiv papers from 288,430 authors.

MEGSA: A powerful and flexible framework for analyzing mutual exclusivity of tumor mutations

By Xing Hua, Paula L. Hyland, Jing Huang, Bin Zhu, Neil E. Caporaso, Maria Teresa Landi, Nilanjan Chatterjee, Jianxin Shi

Posted 09 Apr 2015
bioRxiv DOI: 10.1101/017731 (published DOI: 10.1016/j.ajhg.2015.12.021)

The central challenge in tumor sequencing studies is to identify driver genes and pathways, investigate their functional relationships and nominate drug targets. The efficiency of these analyses, particularly for infrequently mutated genes, is compromised when patients carry different combinations of driver mutations. Mutual exclusivity analysis helps address these challenges. To identify mutually exclusive gene sets (MEGS), we developed a powerful and flexible analytic framework based on a likelihood ratio test and a model selection procedure. Extensive simulations demonstrated that our method outperformed existing methods for both statistical power and the capability of identifying the exact MEGS, particularly for highly imbalanced MEGS. Our method can be used for de novo discovery, pathway-guided searches or for expanding established small MEGS. We applied our method to the whole exome sequencing data for fourteen cancer types from The Cancer Genome Atlas (TCGA). We identified multiple previously unreported non-pairwise MEGS in multiple cancer types. For acute myeloid leukemia, we identified a novel MEGS with five genes (FLT3, IDH2, NRAS, KIT and TP53) and a MEGS (NPM1, TP53 and RUX1) whose mutation status was strongly associated with survival (P=6.7×10-4). For breast cancer, we identified a significant MEGS consisting of TP53 and four infrequently mutated genes (ARID1A, AKT1, MED23 and TBL1XR1), providing support for their role as cancer drivers. Keywords: Mutual exclusivity, oncogenic pathways, driver genes, tumor sequencing

Download data

  • Downloaded 569 times
  • Download rankings, all-time:
    • Site-wide: 17,125 out of 65,085
    • In bioinformatics: 2,607 out of 6,438
  • Year to date:
    • Site-wide: 62,162 out of 65,085
  • Since beginning of last month:
    • Site-wide: 51,304 out of 65,085

Altmetric data


Downloads over time

Distribution of downloads per paper, site-wide


Sign up for the Rxivist weekly newsletter! (Click here for more details.)


News